AHA: Semaglutide cuts risk for CVD events in patients without diabetes
Nov 14, 2023
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
Chest ‘e-tattoo’ device may help in early detection of heart disease
By
John Roszkowski
May 09, 2023
A new ultralightweight medical device that attaches to the chest may detect early signs of heart disease in patients.
High cardiovascular health tied to longer life expectancy free of disease
Mar 06, 2023
For those with high cardiovascular health level, no significant difference was seen in disease-free life expectancy based on socioeconomic status.
Long-term PM₂.₅ exposure linked to increased risk for cardiovascular events
Mar 13, 2023
An increased risk for incident acute myocardial infarction, ischemic heart disease mortality and cardiovascular disease mortality was seen with exposure to PM2.5 at moderate versus low concentrations.
Risk for cardiovascular disease increased for patients with celiac disease
Jan 31, 2023
The increased risk was observed despite a lower prevalence of traditional cardiovascular risk factors.
Heart disease still the leading cause of death in the United States
Jan 24, 2024
Death rates from cardiovascular disease have fluctuated over the years and trended upward recently.
Prevalence of cardiovascular risk factors, diseases set to increase
Jun 06, 2024
The annual inflation-adjusted health care costs of cardiovascular risk factors is projected to triple between 2020 and 2050.
AHA presents up-to-date statistics for cardiovascular disease
Jan 25, 2023
19.05 million deaths were estimated for CVD globally in 2020, representing an increase of 18.71% from 2010.
Mental health treatment linked to better outcomes in CAD, heart failure
Mar 22, 2024
Patients receiving mental health treatment were less likely to be rehospitalized, have an emergency department visit or die from any cause.
Fish oil beneficial for reducing risk for cardiovascular disease progression
May 22, 2024
However, supplements may be a risk factor for atrial fibrillation and stroke in the general population.